World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
12212
World Ranking
4396
National Ranking
1994

Masaki Terabe publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Masaki Terabe sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 164 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Masaki Terabe D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Masaki Terabe sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Masaki Terabe is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on immunology and microbiology, with a significant portion of work also contributing to the fields of medicine, oncology, genetics, neurology, and molecular biology.

The scientist's research topics cover several aspects of immune system function and interaction, particularly within cancer contexts. These main topics of study include:

  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • T-cell and B-cell Immunology
  • Phagocytosis and Immune Regulation
  • Glioma Diagnosis and Treatment

Masaki Terabe's recent notable papers include the following publications:

  • "Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma," 2021, Frontiers in Oncology
  • "Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank," 2020, Neuro-Oncology
  • "Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response," 2022, Journal for ImmunoTherapy of Cancer
  • "MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment," 2020, Neuro-Oncology Advances
  • "The Role of NKT Cells in Glioblastoma," 2021, Cells

Frequent co-authors of Masaki Terabe, reflecting ongoing collaborations and research partnerships, include:

  • Mark R. Gilbert
  • Ayaka Hara
  • John C. Hancock
  • Jay A. Berzofsky
  • Hideho Okada

The scientist's work is regularly published in a number of specialized venues, which demonstrates their active engagement in key fields related to neuro-oncology and immunology. Notable publication venues include:

  • Neuro-Oncology
  • Regular and Young Investigator Award Abstracts
  • Neuro-Oncology Advances
  • Frontiers in Oncology
  • The Journal of Immunology

Best Publications

  • Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells

    Chi Ma;Miaojun Han;Bernd Heinrich;Qiong Fu

  • NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway

    Masaki Terabe;So Matsui;Nancy Noben-Trauth;Hangjiong Chen

  • Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance Abrogation Prevents Tumor Recurrence

    Masaki Terabe;So Matsui;Jong-Myun Park;Mizuko Mamura

  • NAFLD causes selective CD4 + T lymphocyte loss and promotes hepatocarcinogenesis

    Chi Ma;Aparna H. Kesarwala;Tobias Eggert;José Medina-Echeverz

  • Progress on new vaccine strategies for the immunotherapy and prevention of cancer

    Jay A. Berzofsky;Masaki Terabe;Sang Kon Oh;Igor M. Belyakov

  • The role of NKT cells in tumor immunity.

    Masaki Terabe;Jay A. Berzofsky

  • Labeling Extracellular Vesicles for Nanoscale Flow Cytometry

    Aizea Morales-Kastresana;Bill Telford;Thomas A. Musich;Katherine McKinnon

  • Immunoregulatory T cells in tumor immunity.

    Masaki Terabe;Jay A Berzofsky

  • A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

    Masaki Terabe;Jeremy Swann;Elena Ambrosino;Pratima Sinha

  • Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.

    Jeong-Seok Nam;Masaki Terabe;Mi-Jin Kang;Helen Chae

  • An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments

    Jeong Seok Nam;Masaki Terabe;Mizuko Mamura;Mizuko Mamura;Mi Jin Kang

  • Role of IL-13 in regulation of anti-tumor immunity and tumor growth

    Masaki Terabe;Jong Myun Park;Jay A. Berzofsky

  • Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis.

    Elena Ambrosino;Masaki Terabe;Ramesh C. Halder;Judy Peng

  • CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.

    David R. Soto-Pantoja;Masaki Terabe;Arunima Ghosh;Lisa A. Ridnour

  • Progress on new vaccine strategies against chronic viral infections

    Jay A. Berzofsky;Jeffrey D. Ahlers;John Edward Janik;John Morris

  • IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis

    Sang Kon Oh;Liyanage P. Perera;Masaki Terabe;Ling Ni

  • NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis

    Masaki Terabe;Jay A. Berzofsky

  • NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis

    Jay A. Berzofsky;Masaki Terabe

  • NKT cell networks in the regulation of tumor immunity.

    Faith C. Robertson;Jay A. Berzofsky;Masaki Terabe

  • A push–pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

    Jeffrey D. Ahlers;Igor M. Belyakov;Masaki Terabe;Rima Koka

Frequent Co-Authors

Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Ira Pastan
Ira Pastan Center for Cancer Research
John C. Morris
John C. Morris Washington University in St. Louis
David Venzon
David Venzon National Institutes of Health
William E. Paul
William E. Paul National Institute of Allergy and Infectious Diseases
Igor M. Belyakov
Igor M. Belyakov University of Michigan–Ann Arbor
Gurdyal S. Besra
Gurdyal S. Besra University of Birmingham
Jane B. Trepel
Jane B. Trepel National Institutes of Health
Tim F. Greten
Tim F. Greten National Institutes of Health
Steven A. Porcelli
Steven A. Porcelli Albert Einstein College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to various healthcare and research careers. For those interested in nursing as a complementary pathway, transitioning from clinical roles to advanced practice is a common route. Resources like fnp to acnp highlight how nurse practitioners can specialize further to work in acute care settings, which is valuable for immunology-related patient management.

For students aiming to expedite their journey into nursing, many turn to accelerated np program options. These programs provide a faster track to becoming a nurse practitioner, blending rigorous coursework with online flexibility—a great match for those balancing other commitments.

Non-nurses interested in entering the field can start with foundational courses available through online bsn programs for non nurses. These programs make nursing degrees more accessible by eliminating some traditional barriers, fostering a diverse cohort of students passionate about healthcare and immunology.

Additionally, accelerated nursing programs offer streamlined admissions processes and intensive curricula designed to quickly prepare students for licensure. These pathways support a faster transition into the nursing workforce, often critical for roles related to immunology research and clinical practice.

Best Scientists Citing Masaki Terabe

Trending Scientists

Recently Published Articles